Net Loss of Lasa Supergenerics reported to Rs 1.46 crore in the quarter ended December 2023 as against net loss of Rs 4.92 crore during the previous quarter ended December 2022. Sales declined 15.90% to Rs 26.66 crore in the quarter ended December 2023 as against Rs 31.70 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales26.6631.70 -16 OPM %3.94-7.76 - PBDT0.61-2.03 LP PBT-2.07-5.12 60 NP-1.46-4.92 70 Powered by Capital Market - Live News

Lasa Supergenerics will hold a meeting of the Board of Directors of the Company on 13 February 2024.Powered by Capital Market - Live News

Net Loss of Lasa Supergenerics reported to Rs 0.02 crore in the quarter ended September 2023 as against net loss of Rs 6.61 crore during the previous quarter ended September 2022. Sales declined 27.81% to Rs 24.30 crore in the quarter ended September 2023 as against Rs 33.66 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales24.3033.66 -28 OPM %4.32-1.04 - PBDT0.57-1.19 LP PBT-2.11-4.28 51 NP-0.02-6.61 100 Powered by Capital Market - Live News

Lasa Supergenerics will hold a meeting of the Board of Directors of the Company on 10 November 2023.Powered by Capital Market - Live News

Lasa Supergenerics announced that the 8th Annual General Meeting (AGM) of the company will be held on 27 September 2023.Powered by Capital Market - Live News